Lansdale, PA, United States of America

Sutthilug Sotthivirat

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.5

ph-index = 1


Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Sutthilug Sotthivirat

Introduction

Sutthilug Sotthivirat is an inventor based in the United States, known for his contributions to pharmaceutical compositions. His work primarily focuses on developing effective treatments for HIV infection.

Latest Patents

Sutthilug Sotthivirat holds a patent for "Solid Pharmaceutical Compositions Containing An Integrase Inhibitor." This patent describes compressed tablets for oral administration containing raltegravir in the form of a pharmaceutically acceptable salt. The tablets consist of an intragranular component that includes an effective amount of an alkali metal salt of raltegravir, optionally a first superdisintegrant, and a binder. Additionally, the extragranular component comprises a second superdisintegrant, a filler, and a lubricant. The patent also outlines methods for preparing the tablets and their use, optionally in combination with other anti-HIV agents, for inhibiting HIV integrase and treating or preventing HIV infection and AIDS.

Career Highlights

Throughout his career, Sutthilug has focused on innovative solutions in the pharmaceutical field. His work has contributed to advancements in HIV treatment, showcasing his commitment to improving patient outcomes.

Collaborations

Sutthilug Sotthivirat has collaborated with Majid Mahjour, working together to enhance the effectiveness of their pharmaceutical innovations.

Conclusion

Sutthilug Sotthivirat's contributions to the field of pharmaceuticals, particularly in HIV treatment, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…